WS #15167

Geopolitical risk has escalated sharply in the Middle East, with reports of Iranian strikes on Saudi oil infrastructure and the UAE's ADNOC Bu Hasa facility. This escalation, combined with Trump's assertion of US strategic control over the Strait of Hormuz, has triggered a significant risk-off environment. The immediate market impact is a divergence between energy beneficiaries and broad industrial/transport bearishness, while the US 10-Year yield holding at a 24-year high of 5.304% complicates the macro backdrop by reinforcing a higher-for-longer rate narrative despite the supply shock. In the technology sector, the narrative is bifurcated. While Google's AI data-center buildout is lifting networking suppliers, the broader AI infrastructure theme is facing regulatory headwinds as OpenAI is sued over a Hugging Face hack, prompting calls for court-ordered limits. Conversely, Synopsys and OpenAI announced a multi-year chip design deal, signaling continued capital commitment to AI hardware despite the legal friction. The $200bn energy investment deal from South Korea further underscores the global pivot toward energy security amid these tensions. Notable sector-specific developments include a consolidation in the chemical sector with Citigroup lowering price targets across Huntsman, Eastman, and Celanese, reflecting demand concerns. In biotech, positive Phase 2 results for Merck and Connect Biopharma provided isolated pockets of strength. Meanwhile, the aviation sector faces a complex landscape with Air France-KLM and Lufthansa bidding for TAP Portugal, even as broader airline stocks are pressured by the oil supply disruption.